Product Name:

NebuSelect™ Recombinant Human NGAL/Lipocalin-2, hFc-tag

Catalog#:

NBL-242262

Description:

NebuSelect™ Recombinant Human NGAL/Lipocalin-2, hFc-tag(Cat#NBL-242262) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Gln21-Gly198.

Species:

Human

Expression System:

HEK293

Molecular Weight: 

The protein has a predicted MW of 47.2 kDa. Due to glycosylation, the protein migrates to 48-52 kDa based on Bis-Tris PAGE result.

Target Name:

NGAL/Lipocalin-2; NGAL; Lipocalin-2; Oncogene 24p3; p25; Siderocalin LCN2; MSFI

Target Information:

Acute kidney injury (AKI) is one of the most common complications of various serious conditions, and early diagnosis is therefore critical for the treatment of AKI. Recent evidence demonstrates that neutrophil gelatinase- associated lipocalin (NGAL) is closely associated with AKI. Several experimental and clinical studies have shown that the expression of urine and serum NGAL increases significantly in AKI. NGAL shows potential to be a new effective early biochemical marker of AKI. Further studies are needed to confirm the significant advantages of NGAL in the diagnosis of early AKI and its value in clinical applications.

Amino Acid Sequence: 

Gln21-Gly198

Purity:

＞95%

Formulation:

see COA

Endotoxin:

＜1EU/ug(LAL Method)

Storage: 

4°C for short term. 

-20°C for long term.

To get more information, please contact us freely.